CSIMarket


Eucrates Biomedical Acquisition Corp   (EUCR)
Other Ticker:  
 
    Sector  Financial    Industry Blank Checks
   Industry Blank Checks
   Sector  Financial


 

Eucrates Biomedical Acquisition Corp

EUCR's Financial Statements and Analysis



Eucrates Biomedical Acquisition Corp reported in II. Quarter net earnings per share of $0.15 an improvement compare to net loss per share of $-1.55 recorded a year ago and decline of -66.67 % from $0.45 earned in I. Quarter (Mar 31 2021).


II. Quarter
Earnings Per Share Revenues
$ 0.15 $  0 Mill
$+1.70     Unch.    



Eucrates Biomedical Acquisition 's Revenue fell by 0 % in II. Quarter (Jun 30 2021) year on year, to $0 million and declined by sequentially.


Eucrates Biomedical Acquisition is Expected to report next financial results on July 14, 2022.

More on EUCR's Income Statement



Eucrates Biomedical Acquisition 's net income of $1 million in II. Quarter increased from net loss of $-5 million 2020 a year ago.

Sequentially net earnings fell by -68.38 % from net income of $1.99 million realized in previous quarter.

More on EUCR's Growth

EUCR's Cash flow In II. Quarter company's net cash flow was $0 million


Eucrates Biomedical Acquisition Corp does not pay out common stock dividend.

In trailing twelve-month period Eucrates Biomedical Acquisition Corp payed $ -0.13 cash per share, on a free-cash flow basis .

Book value grew by 4.70 % sequentially to $1.19 per share, -63.23% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 1.19 per share from $ 1.13.

Company repurchased 0.20 million shares or 4.49 % in II. Quarter.
Debt Coverage Ratio was 205.36.

More on EUCR's Dividends

 Market Capitalization (Millions) 41
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Eucrates Biomedical Acquisition Corp does not pay out common stock dividend.

In trailing twelve-month period Eucrates Biomedical Acquisition Corp payed $ -0.13 cash per share, on a free-cash flow basis .

Book value grew by 4.70 % sequentially to $1.19 per share, -63.23% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 1.19 per share from $ 1.13.

Company repurchased 0.20 million shares or 4.49 % in II. Quarter.
Debt Coverage Ratio was 205.36.

More on EUCR's Balance Sheets

 Market Capitalization (Millions) 41
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FTGI's Profile

Stock Price

FTGI's Financials

Business Description

Fundamentals

Charts & Quotes

FTGI's News

Suppliers

FTGI's Competitors

Customers & Markets

Economic Indicators

FTGI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071